IMMUCELL CORP /DE/ 8-K

What Happened Immucell Corp. (ICCC) filed a Form 8-K on February 9, 2026 (Item 5.02) reporting that two members of its Board of Directors — Steven A. Rosgen and Bryan K. Gathagan — have each notified the company that they prefer not to run for re‑election at the 2026 Annual Meeting of Shareholders. Both directors said their decision is driven by time constraints related to full‑time leadership roles at their respective companies. The filing notes both have been supportive of Immucell’s new strategic direction and management team.

Key Details

• Two directors: Steven A. Rosgen and Bryan K. Gathagan have given notice they will not seek re‑election at the 2026 annual meeting.
• Reason given: time constraints from their full‑time leadership positions.
• Both have been described as supportive of the company’s new strategic direction and management team.
• The Nominating Committee is evaluating Board composition and will factor these future retirements into its ongoing work.

Why It Matters Board departures can lead to changes in corporate governance and oversight; investors should note potential shifts in board composition ahead of the 2026 annual meeting. The company has not reported any immediate resignations or operational/financial impacts in this filing — it is a notice of intent not to run for re‑election and signals the Nominating Committee will consider replacements as part of its ongoing review.